Cipla Tackles Lanreotide Supply Woes, Solidifies India Diabetes Position

 
• By Anju Ghangurde
  
challenges
Tough Q3FY26 for Cipla amid lanreotide supply issues (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Scrip